.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 6,106,848

« Back to Dashboard

Claims for Patent: 6,106,848

Title: Topically applicable O/W emulsions having high glycol content and at least one biologically active agent
Abstract:Stable, topically applicable oil-in-water bioaffecting emulsions having intermediate viscosity, characteristically ranging from 3 to 10 Pa.multidot.s, comprise (a) from 30% to 50% by weight of at least one pro-penetrating glycol, (b) at least one emulsifying agent, advantageously an anionic amphiphilic polymer, and (c) at least one biologically active agent, for example an active agent that modulates skin differentiation and/or proliferation and/or pigmentation, an anti-inflammatory, an antibacterial, an antifungal, etc.
Inventor(s): Preuilh; Isabelle (Le Canet, FR), Willcox; Nathalie (Le Rouret, FR)
Assignee: Centre International de Recherches Dermatologiques (Valbonne, FR)
Application Number:08/935,054
Patent Claims: 1. A stable, topically applicable oil-in-water emulsion which is topically applicable to skin having intermediate viscosity, comprising (a) from 30% to 50% by weight relative to the total weight of said emulsion of at least one glycol, (b) at least one emulsifying agent comprising an anionic amphiphilic polymer, and (c) at least one biologically active agent, wherein said anionic amphiphilic polymer is present in an amount which in the absence of another emulsifying agent results in an emulsion having an intermediate viscosity, wherein said intermediate viscosity is a viscosity which ranges from 3 to 10 Pa.multidot.s (3,000 to 10,000 centipoises), measured with a Brookfield viscometer LVDV II+paddle No. 4, at a speed of 30 revolutions/minutes for thirty seconds, and at a temperature of 25.degree. C..+-.3.degree. C.

2. The oil-in-water emulsion as defined by claim 1, comprising up to 5% by weight relative to the total weight of said emulsion of at least one gelling and/or thickening agent.

3. The oil-in-water emulsion as defined by claim 1, having a pH ranging from 5 to 7.

4. The oil-in-water emulsion as defined by claim 3, having a pH ranging from 5.5 to 6.5.

5. The oil-in-water emulsion as defined by claim 1, wherein said at least one polymeric emulsifier is a crosslinked anionic amphiphilic polymer.

6. The oil-in-water emulsion as defined by claim 1, said anionic amphiphilic polymer comprising the copolymerizate of olefinically unsaturated carboxylic and C.sub.10 -C.sub.30 alkyl ester comonomers.

7. The oil-in-water emulsion as defined by claim 5, said anionic amphiphilic polymer being crosslinked with olefinically unsaturated and non-conjugated polyolefinically unsaturated comonomers.

8. The oil-in-water emulsion as defined by claim 7, said non-conjugated polyolefinically unsaturated comonomer comprising a polyallyl ether.

9. The oil-in-water emulsion as defined by claim 5, said crosslinked anionic amphiphilic polymer comprising from 95% to 60% by weight of recurring acrylic structural units, from 4% to 40% by weight of recurring acrylate structural units, and 0.1% to 6% by weight of a crosslinking comonomer, wherein said percentages are relative to the total weight of said emulsion.

10. The oil-in-water emulsion as defined by claim 5, said crosslinked anionic amphiphilic polymer comprising from 98% to 96% by weight of recurring acrylic structural units, from 1% to 4% by weight of recurring acrylate structural units, and 0.1% to 0.6% by weight of a crosslinking comonomer, wherein said weight percentages are relative to the total weight of said emulsion.

11. The oil-in-water emulsion as defined by claim 1, comprising up to 1% by weight of said at least one emulsifying agent (b).

12. The oil-in-water emulsion as defined by claim 11, comprising from 0.2% to 0.4% by weight of said at least one emulsifying agent (b).

13. The oil-in-water emulsion as defined by claim 1, said at least one glycol (a) comprising a glycol, which promotes penetration of said emulsion into the skin selected from a glycol selected from the group consisting of propylene glycol, dipropylene glycol, propylene glycol dipelargonate, lauroglycol and ethoxydiglycol.

14. The oil-in-water emulsion as defined by claim 13, comprising from 40% to 50% by weight relative to the total weight of said emulsion of said at least one glycol (a).

15. The oil-in-water emulsion as defined by claim 2, said at least one biologically active agent is selected from the group consisting of (c) an agent which modulates at least one of skin differentiation, proliferation and pigmentation; an antibacterial agent, an antiparasitic agent, an antifungal agent, a steroidal anti-inflammatory agent, a non-steroidal anti-inflammatory agent, an anaesthetic agent, an antipruritic agent, an antiviral agent, a keratolytic agent, an anti-free radical agent, an antiseborrhoeic agent, an antidandruff agent, an anti-acne agent, an antimetabolite, an agent for combating hair loss, an antiseptic and combinations thereof.

16. The oil-in-water emulsion as defined by claim 15, comprising from 0.0001% to 20% by weight relative to the total weight of said emulsion of said at least one biologically active agent (c).

17. The oil-in-water emulsion as defined by claim 1, comprising from 5% to 50% by weight relative to the total weight of said emulsion of an oily phase.

18. The oil-in-water emulsion as defined by claim 17, comprising from 10% to 70% by weight of an aqueous phase relative to the total weight of said emulsion.

19. The composition of claim 1, wherein said anionic amphiphilic polymer comprises recurring acrylic structural units and acrylate structural units.

20. The composition of claim 2, wherein said anionic amphiphilic polymer is cross-linked.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc